Sotera Health (SHC) – Research Analysts’ Recent Ratings Updates

Sotera Health (NASDAQ: SHC) has recently received a number of price target changes and ratings updates:

• 11/20/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – Sotera Health was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 11/13/2025 – Sotera Health is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $19.00 price target on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at Piper Sandler from $15.00 to $17.00. They now have a “neutral” rating on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at Barclays PLC from $19.00 to $20.00. They now have an “overweight” rating on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at JPMorgan Chase & Co. from $14.00 to $16.00. They now have a “neutral” rating on the stock.
• 10/31/2025 – Sotera Health had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/8/2025 – Sotera Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 10/2/2025 – Sotera Health had its price target raised by analysts at Barclays PLC from $17.00 to $19.00. They now have an “overweight” rating on the stock.
• 9/27/2025 – Sotera Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.

Insider Activity at Sotera Health

In other Sotera Health news, Director Pincus & Co. Warburg sold 12,000,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the sale, the director owned 61,822,952 shares in the company, valued at $934,144,804.72. This represents a 16.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock in a transaction on Monday, November 10th. The shares were sold at an average price of $15.65, for a total value of $187,800,000.00. Following the completion of the transaction, the director owned 29,215,301 shares of the company’s stock, valued at approximately $457,219,460.65. This trade represents a 29.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 32,000,000 shares of company stock worth $490,000,000. Insiders own 55.12% of the company’s stock.

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.